Gagnon Advisors’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.2M Buy
177,870
+29,645
+20% +$1.68M 7.76% 4
2026
Q1
$9.52M Buy
148,225
+21,163
+17% +$1.93M 7% 6
2025
Q4
$16.5M Hold
127,062
10.49% 1
2025
Q3
$13.7M Hold
127,062
8.45% 2
2025
Q2
$11.7M Hold
127,062
7.88% 1
2025
Q1
$11.3M Sell
127,062
-60,556
-32% -$5.25M 7.94% 2
2024
Q4
$14.4M Sell
187,618
-67,441
-26% -$4.71M 9.23% 1
2024
Q3
$10.8M Hold
255,059
6.99% 3
2024
Q2
$6.67M Buy
255,059
+43,666
+21% +$828K 5.08% 6
2024
Q1
$1.93M Buy
211,393
+62,059
+42% +$373K 1.67% 20
2023
Q4
$411K Hold
149,334
0.36% 24
2023
Q3
$544K Buy
149,334
+15
+0% +$82 0.45% 26
2023
Q2
$890K Buy
149,319
+19,019
+15% +$151K 0.6% 27
2023
Q1
$1.57M Buy
130,300
+107,903
+482% +$1.44M 1.05% 24
2022
Q4
$195K Hold
22,397
0.13% 28
2022
Q3
$649K Sell
22,397
-22,397
-50% -$1.03M 0.42% 29
2022
Q2
$1.86M Hold
44,794
1.13% 26
2022
Q1
$4.54M Buy
44,794
+22,397
+100% +$2.49M 2.09% 21
2021
Q4
$3.3M Buy
22,397
+11,172
+100% +$2.5M 1.31% 24
2021
Q3
$2.81M Buy
+11,225
New +$3.86M 1.12% 28

Other funds holding WGS

Gagnon Advisors's WGS Position: Q2 2026 in Review

Gagnon Advisors increased its GeneDx Holdings (WGS) stake by 20% in Q2 2026, buying an estimated $1.68M and bringing the position to 177,870 shares worth $12.2M. The position accounts for 7.76% of the portfolio, ranked #4.

Gagnon Advisors first reported a position in WGS in Q3 2021 and has held it in 20 quarters since. The position peaked at $16.5M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Gagnon Advisors held 177,870 shares of GeneDx Holdings worth $12.2M as of Q2 2026.
  • Gagnon Advisors bought 29,645 GeneDx Holdings shares in Q2 2026, an estimated $1.68M.
  • GeneDx Holdings made up 7.76% of Gagnon Advisors's portfolio in Q2 2026, its #4 holding.
  • Gagnon Advisors first reported a position in GeneDx Holdings in Q3 2021 and has held it in 20 quarters since.
  • Gagnon Advisors's GeneDx Holdings position peaked at $16.5M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Gagnon Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.